Market Research Logo

Optical Imaging System Market Analysis By Technology (Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy), By Product (Imaging Systems, Optical Imaging Software, Cameras, Illumination Systems, Lenses)

Optical Imaging System Market Analysis By Technology (Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy), By Product (Imaging Systems, Optical Imaging Software, Cameras, Illumination Systems, Lenses), By Application (Pathological Imaging, Intraoperative Imaging), By End Use , By Therapeutic Area (Ophthalmology, Cardiology, Oncology, Dermatology, Neurology) And Segment Forecasts To 2024

The global optical imaging system market is expected to reach USD 3.0 billion by 2024, according to a new report by Grand View Research, Inc. Technological advancements and rising preference for noninvasive technology are anticipated to be the preliminary market catalyst.

Rising R&D efforts by pharmaceutical and biotechnological companies requiring the use of optical imaging systems are encouraging the market growth. Additionally, veterinary hospitals and educational institutions are utilizing this technology in research and diagnostics, due to its noninvasive nature.

North America and Europe together accounted for the largest market share that was over 60.0% in 2015. Well-developed research infrastructure, availability of skilled professionals, and faster adoption rates of technically advanced devices within the region are certain factors promoting growth. Furthermore, supportive government initiatives in this region are propelling the growth in this sector. The government of Canada invested around USD 750,000 in the Canadian Imaging Research Center to promote research and commercialization opportunities in the imaging sector.

Asia Pacific is expected to witness the fastest growth rate during the forecast period owing to the easy availability of resources. Favorable environment is encouraging research activities as government funding for R&D is increasing in emerging nations, such as India and China. For instance, Impacting Research Innovation and Technology (IMPRINT), an initiative by the Indian government, promotes R&D in imaging and other technology sectors. This is expected to attract market players to this region, thereby facilitating higher penetration and expansion.

Further Key Findings From the Study Suggest:

The optical coherence tomography segment is the largest segment over the forecast period. The largest share was attributed to the extensive application in small animal imaging and research projects.

North America captured the largest market share of around 35.0% in 2015. The market is expected to maintain its dominance during the forecast period. Technologically advanced research infrastructure and increasing use in medical testing for chronic conditions are some of the factors supporting the growth in this region.

Asia Pacific is anticipated to witness a significant growth rate from 2016 to 2024 owing to the government initiatives in this region. For instance, the Asia-Pacific Optical Sensors Conference held every year by the Optical Society helps showcase new products to consumer, thereby increasing awareness regarding the market and its developments.

Some key players are PerkinElmer, Inc., St. Jude Medical, Inc., Carl Zeiss Meditec AG, Topcon Corporation, and Koninklijke Philips N.V.

In order to curb the competition, key industry players are meticulously involved in the development of new systems that facilitate easy diagnosis. For instance, the Dragonfly Catheter series by St. Jude Medical, Inc. provides data sampling of around 100 MB per second.


Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumption
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Optical Imaging System Market - Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Optical Imaging System Industry Outlook
3.1. Market Segmentation
3.2. Optical Imaging System Market Size and Growth Prospects
3.3. Optical Imaging System Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising prevalence of ophthalmic disorders
3.3.1.2. Technological advancements
3.3.1.3. Increasing preference for noninvasive technology
3.3.1.4. Widening areas of application
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of Skilled Operators
3.3.2.2. High Cost and Data Requirement
3.4. Key Opportunities Prioritized
3.5. Industry Analysis -Porter's
3.6. Optical Imaging System Market PESTEL Analysis, 2015
Chapter 4. Optical Imaging System Market by Technology
4.1. Optical Imaging System Market Share, by Technology, 2015 & 2024 (USD Million)
4.2. Photoacoustic Tomography
4.2.1. Photoacoustic Tomography Market Estimates & Forecasts, 2013 - 2024 (USD Million)
4.3. Optical Coherence Tomography
4.3.1. Optical Coherence Tomography Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.4. Hyperspectral Imaging
4.4.1. Hyperspectral Imaging Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.5. Near-Infrared Spectroscopy
4.5.1. Near-Infrared Spectroscopy Market Estimates & Forecasts, 2013 - 2024 (USD Million)
Chapter 5. Optical Imaging System Market by Product
5.1. Optical Imaging System Market Share, by Product, 2015 & 2024 (USD Million)
5.2. Imaging Systems
5.2.1. Imaging Systems Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.2.1.1. Optical imaging systems market estimates & forecasts, 2013 - 2024 (USD Million)
5.2.1.2. Spectral imaging systems Market estimates & forecasts, 2013 - 2024 (USD Million)
5.3. Optical Imaging Software
5.3.1. Optical Imaging Software Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.4. Cameras
5.4.1. Cameras Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.5. Illumination Systems
5.5.1. Illumination Systems Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.6. Lenses
5.6.1. Lenses Market Estimates and Forecasts, 2013 - 2024 (USD Million)
5.7. Other Optical Imaging Products
5.7.1. Other Optical Imaging Products Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 6. Optical Imaging System Market by Application
6.1. Optical Imaging System Market Share, by Application, 2015 & 2024 (USD Million)
6.2. Pathological Imaging
6.2.1. Pathological Imaging Market Estimates and Forecasts, 2013 - 2024 (USD Million)
6.3. Intraoperative Imaging
6.3.1. Intraoperative Imaging Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 7. Optical Imaging System Market by End Use
7.1. Optical Imaging System Market Share, by End Use,2015 & 2024 (USD Million)
7.2. Research Laboratories
7.2.1. Research Laboratories Market Estimates and Forecasts, 2013 - 2024 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Hospital & Clinics Market Estimates and Forecasts, 2013 - 2024 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 8. Optical Imaging System Market by Therapeutic Area
8.1. Optical Imaging System Market Share, by Therapeutic Area, 2015 & 2024 (USD Million)
8.2. Ophthalmology
8.2.1. Ophthalmology Market Estimates and Forecasts, 2013 -2024 (USD Million)
8.3. Cardiology
8.3.1. Cardiology Market Estimates and Forecasts, 2013 - 2024 (USD Million)
8.4. Oncology
8.4.1. Oncology Market Estimates and Forecasts, 2013 - 2024 (USD Million)
8.5. Dermatology
8.5.1. Dermatology Market Estimates and Forecasts, 2013 - 2024 (USD Million)
8.6. Neurology
8.6.1. Neurology Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 9. Optical Imaging System Market by Region
9.1. Optical Imaging System Market Share, by Region,2015 & 2024 (USD Million)
9.2. North America
9.2.1. North America Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.2.2.2. U.S. Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.2.2.3. U.S. Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.2.2.4. U.S. Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.2.2.5. U.S. Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.2.2.6. U.S. Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.2.3.2. Canada Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.2.3.3. Canada Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.2.3.4. Canada Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.2.3.5. Canada Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.2.3.6. Canada Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.3. Europe
9.3.1. Europe Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.3.2. UK
9.3.2.1. UK Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.3.2.2. UK Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.3.2.3. UK Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.3.2.4. UK Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.3.2.5. UK Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.3.2.6. UK Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.3.3.2. Germany Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.3.3.3. Germany Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.3.3.4. Germany Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.3.3.5. Germany Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.3.3.6. Germany Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.4.2. Japan
9.4.2.1. Japan Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.4.2.2. Japan Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.4.2.3. Japan Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.4.2.4. Japan Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.4.2.5. Japan Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.4.2.6. Japan Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.4.3. China
9.4.3.1. China Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.4.3.2. China Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.4.3.3. China Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.4.3.4. China Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.4.3.5. China Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.4.3.6. China Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.5. Latin America
9.5.1. Latin America Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.5.2.2. Japan Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.5.2.3. Brazil Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.5.2.4. Brazil Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.5.2.5. Brazil Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.5.2.6. Brazil Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.5.3. Mexico
9.5.3.1. Mexico Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.5.3.2. Mexico Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.5.3.3. Mexico Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.5.3.4. Mexico Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.5.3.5. Mexico Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.5.3.6. Mexico Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.6. MEA
9.6.1. MEA Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.6.2.2. South Africa Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.6.2.3. South Africa Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.6.2.4. South Africa Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.6.2.5. South Africa Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.6.2.6. South Africa Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2013 - 2024 (USD Million)
9.6.3.2. Saudi Arabia Market Estimates and Forecasts by Technology 2013 - 2024 (USD Million)
9.6.3.3. Saudi Arabia Market Estimates and Forecasts by Product 2013 - 2024 (USD Million)
9.6.3.4. Saudi Arabia Market Estimates and Forecasts by Application 2013 - 2024 (USD Million)
9.6.3.5. Saudi Arabia Market Estimates and Forecasts by End Use 2013 - 2024 (USD Million)
9.6.3.6. Saudi Arabia Market Estimates and Forecasts by Therapeutic Area 2013 - 2024 (USD Million)
Chapter 10. Competitive Landscape
10.1. St. Jude Medical, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. PerkinElmer, Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Koninklijke Philips
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Strategic Initiatives
10.4. Carl Zeiss Meditec AG
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Strategic Initiatives
10.5. Topcon Corporation
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Strategic Initiatives
10.6. Bioptigen, Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. Canon, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Strategic Initiatives
10.8. Heidelberg Engineering, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Strategic Initiatives
10.9. Optovue, Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Headwall Photonics, Inc.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report